Preclinical evaluation of PEGylated liposomal doxorubicin as an effective radiosensitizer in chemoradiotherapy for lung cancer.

Jenny Ling-Yu ChenChun-Kai PanYu-Li LinChing-Yi TsaiYu-Sen HuangWen-Chi YangFeng-Ming HsuSung-Hsin KuoMing-Jium Shieh

Published in: Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al] (2021)

Our study provides preclinical in vitro and in vivo evidence of the effectiveness of PEGylated liposomal doxorubicin as a radiosensitizer, supporting its potential clinical development as a component of chemoradiotherapy.

Keyphrases

rectal cancer
locally advanced
drug delivery
randomized controlled trial
cancer therapy
systematic review
bone marrow